.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Dow
Express Scripts
Baxter
Mallinckrodt
Daiichi Sankyo
Healthtrust
McKinsey
Cipla
Covington

Generated: September 23, 2017

DrugPatentWatch Database Preview

Sodium phosphate p-32 - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium phosphate p-32 and what is the scope of sodium phosphate p-32 freedom to operate?

Sodium phosphate p-32
is the generic ingredient in two branded drugs marketed by Bracco and Mallinckrodt, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand three hundred and ninety-two drug master file entries for sodium phosphate p-32.

Summary for Generic Name: sodium phosphate p-32

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list1392
Clinical Trials: see list3,083
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sodium phosphate p-32 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt
SODIUM PHOSPHATE P 32
sodium phosphate p-32
SOLUTION;INJECTION, ORAL011777-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
PHOSPHOTOPE
sodium phosphate p-32
SOLUTION;INJECTION, ORAL010927-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt
SODIUM PHOSPHATE P 32
sodium phosphate p-32
SOLUTION;INJECTION, ORAL011777-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Express Scripts
McKesson
Dow
Cipla
Cerilliant
Citi
Chinese Patent Office
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot